Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I TAMM

Showing results (1-10 of 102) with videos related to

Pageof 11
Sort By:
Biochemical Pharmacology|February 15, 1984
HeLa cell RNA and protein syntheses. Effects of long-term treatment with 5,6-dichloro-1-beta-D-ribofuranosylbenzimidazole (DRB)I Tamm
Das Offentliche Gesundheitswesen|February 1, 1990
[Decrease in tuberculosis mortality--a credit to medicine or sequela of an improved standard of living]I Tamm
The Journal of Experimental Medicine|October 1, 1973
Benzimidazole derivatives: new enhancers of influenza virus multiplicationI Tamm
Proceedings of the National Academy of Sciences of the United States of America|November 1, 1977
Definition of subclasses of nucleoplasmic RNAI Tamm
The American Journal of Pathology|October 1, 1975
Cell injury with virusesI Tamm
Journal of Cellular Physiology|July 1, 1983
Recovery of HeLa cell population growth after treatment with 5,6-dichloro-1-beta-D-ribofuranosylbenzimidazole (DRB)I Tamm
Das Offentliche Gesundheitswesen|March 1, 1990
[The status of tuberculosis since World War II]I Tamm
Journal of Cellular Physiology|July 1, 1991
Activation of signal transduction pathways protects quiescent Balb/c-3T3 fibroblasts against death due to serum deprivationI Tamm, T Kikuchi
Journal of Cellular Physiology|June 1, 1990
Insulin-like growth factor-1 (IGF-1), insulin, and epidermal growth factor (EGF) are survival factors for density-inhibited, quiescent Balb/c-3T3 murine fibroblastsI Tamm, T Kikuchi
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.)|June 1, 1983
Inhibition of HeLa-S3 cell proliferation and biosynthesis by 5,6-dichloro-1-beta-D-ribofuranosylbenzimidazole (DRB)I Tamm, T Kikuchi
Pageof 11

Showing results (1-10 of 102) with videos related to

Sort By:
Pageof 11
Biochemical Pharmacology|February 15, 1984
HeLa cell RNA and protein syntheses. Effects of long-term treatment with 5,6-dichloro-1-beta-D-ribofuranosylbenzimidazole (DRB)I Tamm
Das Offentliche Gesundheitswesen|February 1, 1990
[Decrease in tuberculosis mortality--a credit to medicine or sequela of an improved standard of living]I Tamm
The Journal of Experimental Medicine|October 1, 1973
Benzimidazole derivatives: new enhancers of influenza virus multiplicationI Tamm
Proceedings of the National Academy of Sciences of the United States of America|November 1, 1977
Definition of subclasses of nucleoplasmic RNAI Tamm
The American Journal of Pathology|October 1, 1975
Cell injury with virusesI Tamm
Journal of Cellular Physiology|July 1, 1983
Recovery of HeLa cell population growth after treatment with 5,6-dichloro-1-beta-D-ribofuranosylbenzimidazole (DRB)I Tamm
Das Offentliche Gesundheitswesen|March 1, 1990
[The status of tuberculosis since World War II]I Tamm
Journal of Cellular Physiology|July 1, 1991
Activation of signal transduction pathways protects quiescent Balb/c-3T3 fibroblasts against death due to serum deprivationI Tamm, T Kikuchi
Journal of Cellular Physiology|June 1, 1990
Insulin-like growth factor-1 (IGF-1), insulin, and epidermal growth factor (EGF) are survival factors for density-inhibited, quiescent Balb/c-3T3 murine fibroblastsI Tamm, T Kikuchi
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.)|June 1, 1983
Inhibition of HeLa-S3 cell proliferation and biosynthesis by 5,6-dichloro-1-beta-D-ribofuranosylbenzimidazole (DRB)I Tamm, T Kikuchi
Pageof 11